Loading company…
Rivia develops AI analytics and data infrastructure for clinical trial data.
Founded in 2022 in Zurich, Switzerland, Rivia develops software to help therapeutic companies manage, harmonize and analyze clinical trial data. Its platform supports data visualization, self-service analysis, visit scheduling and hypothesis testing. In March 2026, the company raised EUR 13 million in Series A funding led by Earlybird, with Defiant, Speedinvest, Amino Collective and Nina Capital participating. The funding will support hiring, product development and US expansion.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in